AstraZeneca reviews potential Bristol Myers deal, Barclays comments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 1,013,103 | |||||
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.58 | 52 Week High | $77.12 | |||
| Open | $58.88 | 52 Week Low | $49.03 | |||
| Day High | $59.79 | P/E | 38.69 | |||
| Day Low | $58.74 | EPS | $1.54 | |||
| Volume | 3,136,788 | |||||
